[CAS NO. 2508-72-7]??Antazoline hydrochloride
PRODUCTS SPECIFICATIONS [2508-72-7]
DESCRIPTION [2508-72-7]
Overview
| MDL | MFCD00058145 |
|---|---|
| Molecular Weight | 301.81 |
| Molecular Formula | C17H20ClN3 |
| SMILES | [H]Cl.C1(CN(C2=CC=CC=C2)CC3=CC=CC=C3)=NCCN1 |
Summary
Antazoline hydrochloride is a 1st generation antihistamine with also anticholinergic properties used to relieve nasal congestion and in eye drops.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT01527279 | Institute of Cardiology, Warsaw, Poland |
Paroxysmal Atrial Fibrillation
|
November 2012 | Phase 4 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
DMSO : ≥ 53 mg/mL ( 175.61 mM )
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 3.3133 mL | 16.5667 mL | 33.1334 mL |
| 5 mM | 0.6627 mL | 3.3133 mL | 6.6267 mL |
| 10 mM | 0.3313 mL | 1.6567 mL | 3.3133 mL |
Synonyms